Lamivudine and Zidovudine Tablets
Description:
Lamivudine and Zidovudine Tablets is a fixed-dose combination of two antiretroviral medications used in the treatment of HIV (Human Immunodeficiency Virus) infection. This combination belongs to the class of nucleoside reverse transcriptase inhibitors (NRTIs) and works by inhibiting the reverse transcriptase enzyme, essential for viral replication. The therapy helps lower the viral load in the body, supports immune function, and delays the progression to AIDS (Acquired Immunodeficiency Syndrome).
Therapeutic Uses:
Treatment of HIV-1 infection in adults and adolescents
Administered as part of a combination antiretroviral therapy (ART) regimen
Mechanism of Action:
Both Lamivudine and Zidovudine inhibit reverse transcriptase, an enzyme critical for HIV replication. Their synergistic action enhances viral suppression and reduces the risk of drug resistance.
Packaging:
Commonly available in blister packs or bottles, often in pack sizes such as 10x10 tablets (100 tablets per box), or customized as per export or regulatory needs.
Note:
This medication should be used under the guidance of a qualified healthcare professional. Routine monitoring of viral load, liver function, and blood counts is recommended during treatment.
Would you like a version tailored for export catalogs or pharmacy listings?
